Shares of Outset Medical, Inc. (OM) are rising more than 12% Wednesday morning at $20.14.
There have been no company-specific news today to propel the stock.
Early in the month, a the company had reported a revenue growth of 5.5% year-on-year to $27.8 million for its third quarter.
The company also had increased its full-year revenue outlook to $111 million-$113 million from $105 million-$110 million projected earlier.
On November 16, Outset had said it ranked 33 on the Deloitte Technology Fast 500, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America.
Outset revenue grew 5,000 percent to $103 million between 2018 and 2021.
Outset Medical is a medical technology company, that develops a hemodialysis system for dialysis.
OM has traded in the range of $11.41-$51.69 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.